Le Lézard
Classified in: Health
Subject: AVO

HEALTH GROUPS STRANGELY OPPOSE EFFECTIVE AND PROVEN SMOKING CESSATION PRODUCTS


TORONTO, Feb. 21, 2024 /CNW/ - Public health groups across the country have found a new enemy in their war on nicotine: smoking cessation products. These so-called health groups are pushing to make life saving products harder to buy and less appealing than cigarettes.

"These are organizations whose goal is the health and well-being of Canadians. They have lost their way. Shouldn't they be making sure that smoking cessation products are available to adults who smoke and easy for them to purchase?" said Maria Papaioannoy, spokesperson for Rights4Vapers. "We fought to keep vaping accessible. We will fight for all kinds of effective smoking cessation products."

In a costly full-page ad, the Canadian Cancer Society, Canadian Lung Association, Physicians for a Smokefree Canada, Action on Smoking and Health, Heart and Stroke, and the Quebec Coalition for Tobacco Control are calling on the federal government to ban all flavours in smoking cessation products and make them prescription only.

History has shown us that prohibition does not work.

"Look what has happened in Quebec. The provincial government banned flavoured vaping products only for it to be replaced by black market, unregulated, untaxed vapes in every flavour you can imagine," said Valerie Gallant, spokesperson for the Coalition des droit des vapoteurs du Québec. "Flavours are not the problem. Lack of enforcement, inaccurate information and misleading communications are."

Flavours have become one of the most controversial areas of the nicotine debate. The role of flavours in vaping and quit smoking products is complex. Adults who smoke say that flavours give them a reason to switch from the traditional cigarette. Having less-harmful alternatives that does not taste like tobacco is critical for smokers to initially make the switch and stick with it. 

The Minister of Health's previous work in tobacco control should make him sensitive to the needs of Canadians who smoke, and he should be the first person in line to recognize the potential of these products to stop smoking.

His own tobacco control strategy states: "We are committed to working with the provinces and territories to significantly revamp smoking cessation services across the country, to make it easier, faster and more appealing for smokers to access the support and tools they need in a way that best works for them."

"Minister Holland, we have the same objective: to help people who smoke quit. I was one of them. I don't smoke anymore thanks to vaping. Let's give all Canadians who smoke the same chance," said Ms. Papaioannoy.

SOURCE Rights 4 Vapers


These press releases may also interest you

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...



News published on and distributed by: